Advanced search
1 file | 514.60 KB
Author
Organization
Abstract
We review the various aspects of health technology assessment in osteoporosis, including epidemiology and burden of disease, and assessment of the cost-effectiveness of recent advances in the treatment of osteoporosis and the prevention of fracture, in the context of the allocation of health-care resources by decision makers in osteoporosis. This article was prepared on the basis of a symposium held by the Belgian Bone Club and the discussions surrounding that meeting and is based on a review and critical appraisal of the literature. Epidemiological studies confirm the immense burden of osteoporotic fractures for patients and society, with lifetime risks of any fracture of the hip, spine, and forearm of around 40 % for women and 13 % for men. The economic impact is also large; for example, Europe's six largest countries spent a,not sign31 billion on osteoporotic fractures in 2010. Moreover, the burden is expected to increase in the future with demographic changes and increasing life expectancy. Recent advances in the management of osteoporosis include novel treatments, better fracture-risk assessment notably via fracture risk algorithms, and improved adherence to medication. Economic evaluation can inform decision makers in health care on the cost-effectiveness of the various interventions. Cost-effectiveness analyses suggest that the recent advances in the prevention and treatment of osteoporosis may constitute an efficient basis for the allocation of scarce health-care resources. In summary, health technology assessment is increasingly used in the field of osteoporosis and could be very useful to help decision makers efficiently allocate health-care resources.
Keywords
Cost-effectiveness, Burden of disease, Economic evaluation, Health technology assessment, Osteoporosis, HIP FRACTURE INCIDENCE, OF-THE-LITERATURE, DISCRETE-CHOICE EXPERIMENTS, CARE DECISION-MAKING, BONE-MINERAL DENSITY, ECONOMIC-EVALUATION, COST-EFFECTIVENESS, POSTMENOPAUSAL OSTEOPOROSIS, INTERVENTION THRESHOLDS, MEDICATION ADHERENCE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 514.60 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Hiligsmann, Mickael, John A Kanis, Juliet Compston, Cyrus Cooper, Bruno Flamion, Pierre Bergmann, Jean-Jacques Body, et al. 2013. “Health Technology Assessment in Osteoporosis.” Calcified Tissue International 93 (1): 1–14.
APA
Hiligsmann, Mickael, Kanis, J. A., Compston, J., Cooper, C., Flamion, B., Bergmann, P., Body, J.-J., et al. (2013). Health technology assessment in osteoporosis. CALCIFIED TISSUE INTERNATIONAL, 93(1), 1–14.
Vancouver
1.
Hiligsmann M, Kanis JA, Compston J, Cooper C, Flamion B, Bergmann P, et al. Health technology assessment in osteoporosis. CALCIFIED TISSUE INTERNATIONAL. 2013;93(1):1–14.
MLA
Hiligsmann, Mickael, John A Kanis, Juliet Compston, et al. “Health Technology Assessment in Osteoporosis.” CALCIFIED TISSUE INTERNATIONAL 93.1 (2013): 1–14. Print.
@article{4121740,
  abstract     = {We review the various aspects of health technology assessment in osteoporosis, including epidemiology and burden of disease, and assessment of the cost-effectiveness of recent advances in the treatment of osteoporosis and the prevention of fracture, in the context of the allocation of health-care resources by decision makers in osteoporosis. This article was prepared on the basis of a symposium held by the Belgian Bone Club and the discussions surrounding that meeting and is based on a review and critical appraisal of the literature. Epidemiological studies confirm the immense burden of osteoporotic fractures for patients and society, with lifetime risks of any fracture of the hip, spine, and forearm of around 40 % for women and 13 % for men. The economic impact is also large; for example, Europe's six largest countries spent a,not sign31 billion on osteoporotic fractures in 2010. Moreover, the burden is expected to increase in the future with demographic changes and increasing life expectancy. Recent advances in the management of osteoporosis include novel treatments, better fracture-risk assessment notably via fracture risk algorithms, and improved adherence to medication. Economic evaluation can inform decision makers in health care on the cost-effectiveness of the various interventions. Cost-effectiveness analyses suggest that the recent advances in the prevention and treatment of osteoporosis may constitute an efficient basis for the allocation of scarce health-care resources. In summary, health technology assessment is increasingly used in the field of osteoporosis and could be very useful to help decision makers efficiently allocate health-care resources.},
  author       = {Hiligsmann, Mickael and Kanis, John A and Compston, Juliet and Cooper, Cyrus and Flamion, Bruno and Bergmann, Pierre and Body, Jean-Jacques and Boonen, Steven and Bruyère, Olivier and Devogelaer, Jean-Pierre and Goemaere, Stefan and Kaufman, Jean and Rozenberg, Serge and Reginster, Jean-Yves},
  issn         = {0171-967X},
  journal      = {CALCIFIED TISSUE INTERNATIONAL},
  keywords     = {Cost-effectiveness,Burden of disease,Economic evaluation,Health technology assessment,Osteoporosis,HIP FRACTURE INCIDENCE,OF-THE-LITERATURE,DISCRETE-CHOICE EXPERIMENTS,CARE DECISION-MAKING,BONE-MINERAL DENSITY,ECONOMIC-EVALUATION,COST-EFFECTIVENESS,POSTMENOPAUSAL OSTEOPOROSIS,INTERVENTION THRESHOLDS,MEDICATION ADHERENCE},
  language     = {eng},
  number       = {1},
  pages        = {1--14},
  title        = {Health technology assessment in osteoporosis},
  url          = {http://dx.doi.org/10.1007/s00223-013-9724-8},
  volume       = {93},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: